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Abstract 13
In 1972, an outbreak of neurorespiratory disease in a Swiss  14
serpentarium formed the basis for the first description of a  15
paramyxovirus isolated from a reptile. In the forty years since this  16
outbreak, there have been over 50 published reports about reptilian  17
paramyxoviruses from all over the world. The majority of these  18
investigations have concerned themselves with ferlaviruses (sometimes  19
previously referred to as ophidian paramyxoviruses, or OPMV). The  20
biology of these viruses is reviewed and this is followed by a review of  21
the clinical findings that are associated with ferlaviral infection and the  22
various diagnostic tests that are used to identify infected reptiles.  23
Recently, a second, and highly divergent, reptilian paramyxovirus,  24
Sunshine virus, was described in Australian pythons, so it is an  25
opportune time to reflect on the paramyxoviruses that infect reptiles. 26Page 2 of 49
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Introduction 29
A wide range of viruses have been detected in reptiles throughout the  30
world and the interested reader is referred to the reviews by Wellehan  31
and Johnson (2005), Jacobson (2007), Marschang (2011) and Ariel (2011) 32
for more general overviews of these viruses. This review will focus on  33
the paramyxovirus infections of reptiles. Since an outbreak of  34
neurorespiratory disease in a Swiss serpentarium that was associated  35
with a paramyxovirus (Folsch and Leloup, 1976), reptilian  36
paramyxoviruses have been described in other regions of Europe (Ahne 37
et al., 1987; Blahak, 1995; Manvell et al., 2000; Franke et al., 2001), USA  38
(Jacobson et al., 1980; Jacobson et al., 1981; Potgieter et al., 1987;  39
Richter et al., 1996) and Brazil (Nogueira et al., 2002; Kolesnikovas et al.,  40
2006). Most recently, a novel paramyxovirus, named Sunshine virus,  41
was described in Australian pythons (Hyndman et al., 2012a; Hyndman  42
et al., 2012b) and so it is important to review the established and  43
emerging areas in this field. 44
Taxonomy of Reptilian Paramyxoviruses 45
Members of the family Paramyxoviridae are currently divided into two  46
subfamilies: Pneumovirinae and Paramyxovirinae (ICTV, 2013).  47
Paramyxovirinae currently contains seven genera, one of which is the  48Page 3 of 49
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genus Ferlavirus. Prior to the discovery of Sunshine virus, all  49
phylogenetically-characterised reptilian paramyxoviruses have clustered  50
within Ferlavirus (Marschang et al., 2009). Sunshine virus clusters within  51
Paramyxoviridae but outside of both subfamilies and therefore  52
broadens our understanding of the diversity of paramyxoviruses that  53
infect reptiles (Hyndman et al., 2012a). 54
Ferlavirus 55
The literature has not shown conformity in how it refers to ferlaviruses.  56
Since the first characterisation of a snake paramyxovirus that was  57
named Fer de Lance Virus (FDLV) (Clark et al., 1979), the term ophidian  58
paramyxovirus (often abbreviated to OPMV or oPMV) has also been  59
used to describe the paramyxoviruses found in snakes (Lloyd and  60
Flanagan, 1991; Homer et al., 1995; Jacobson et al., 1997; Manvell et al.,  61
2000; Kindermann et al., 2001; Oros et al., 2001; Nogueira et al., 2002;  62
Kolesnikovas et al., 2006). In 2009, a proposal was put forward by  63
Kurath to the International Committee on Taxonomy of Viruses (ICTV) to  64
create the new genus Ferlavirus with Fer-de-Lance paramyxovirus (the  65
same virus as FDLV) as its type species. This proposal has been accepted  66
by the ICTV (2013) and all future work should refer to these viruses as  67
ferlaviruses. By avoiding the general term “ophidian paramyxovirus”,  68
Sunshine virus and the ferlaviruses of snakes can be unambiguously  69
delineated. 70
71Page 4 of 49
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Folsch and Leloup (1976) produced the first report of a reptilian  72
paramyxovirus following an outbreak of neurorespiratory disease in a  73
Swiss serpentarium. The physicochemical traits of this first isolate were  74
then characterised and described by Clark et al. (1979). The origin of the  75
ferlaviruses is unknown but one reference provides further insight. A  76
personal communication mentioned in a paper by Kolesnikovas et al.  77
(2006) states that the Brazilian lancehead vipers (Bothrops moojeni but  78
incorrectly referred to as Fer-de-Lance vipers [B.atrox] in earlier works)  79
in the Swiss serpentarium originated from Brazil. No further information  80
is provided. 81
82
The entire genome of Fer-de-Lance paramyxovirus has been sequenced  83
(Kurath et al., 2004). The genome is 15,378 nucleotides long and is  84
made up of seven distinct genes: 3’ – Nucleocapsid (N) – Unknown (U) – 85
Phosphoprotein/Protein V (P/V) – Matrix (M) – Fusion (F) – 86
Haemagglutinin-Neuraminidase (HN) – RNA-Dependent RNA  87
Polymerase (L). The fusion gene has been analysed by others (Franke et  88
al., 2006). Several authors have analysed the phylogenetic relationships  89
that exist between ferlaviruses (Ahne et al., 1999b; Franke et al., 2001;  90
Kindermann et al., 2001; Marschang et al., 2009; Papp et al., 2010a;  91
Papp et al., 2010b; Abbas et al., 2011) while others have compared the  92
ferlaviruses to other paramyxoviruses (Junqueira de Azevedo et al.,  93
2001; Kurath et al., 2004; Marschang et al., 2009). These studies  94
support the classification of the squamate ferlaviruses as a single genus  95Page 5 of 49
Accepted Manuscript
containing at least three distinct genogroups (A, B and C). The clinical  96
significance and serodiagnostic implications of the different genotypes  97
remains undefined. 98
99
The serological relatedness of ferlaviruses to other paramyxoviruses has  100
been reported by several authors (Clark et al., 1979; Potgieter et al.,  101
1987; Blahak, 1995; Richter et al., 1996; Ahne et al., 1999b). Clark et al. 102
(1979) titrated antisera against 19 myxoviruses (16 paramyxoviruses  103
and 3 orthomyxoviruses) against Fer-de-Lance paramyxovirus and then  104
did the reverse by titrating ferlavirus antisera against the same suite of  105
myxoviruses. No cross-reactivity was detected. Richter et al. (1996) 106
showed that the antisera specific for eight paramyxoviruses did not  107
inhibit the haemagglutinating ability of three ferlaviral isolates. Ahne et  108
al. (1999b) was also unable to demonstrate any cross-reactivity  109
between ferlaviral antisera and a range of paramyxoviruses. 110
111
In contrast to these findings, serological relationships between  112
ferlaviruses and other paramyxoviruses have been shown by other  113
authors. Blahak (1995) demonstrated a serological relationship between  114
ferlavirus and Avian paramyxovirus types 1 and 7 (aPMV-1 and -7),  115
while Gravendyck et al. (1998) reported on the cross-reactivity of a  116
paramyxovirus from a monitor (Varanus prasinus) with aPMV-7. Later,  117
Manvell et al. (2000) classified two isolates of ferlavirus as “ophidian  118
paramyxovirus type 1 (PMV-1) and ophidian paramyxovirus type 7  119Page 6 of 49
Accepted Manuscript
(PMV-7)” based on the strength of their serological cross-reactivity with  120
antisera against aPMV-1 and -7. In another report, Potgieter et al. (1987) 121
used immunohistochemical staining to detect ferlavirus in a section of  122
infected snake lung after the lung had been treated with the  123
fluorescently-labelled antisera of Parainfluenza virus type 2. 124
125
The incongruence that exists in the conclusions of the studies on  126
ferlaviral serological relatedness could be explained by a serological  127
unrelatedness between the various ferlaviral isolates used in these  128
studies. Serological unrelatedness between ferlaviral isolates has been  129
shown in at least two studies (Marschang et al., 2002; Allender et al.,  130
2008). In general, however, it seems reasonable to conclude that the  131
serological relatedness of the ferlaviruses to other paramyxoviruses is  132
limited at most. 133
134
All ferlaviruses are believed to have neuraminidase activity. Using a  135
substrate that is specifically cleaved by neuraminidase into an intensely  136
fluorescent product (Yolken et al., 1980), significant neuraminidase  137
activity was detected in three isolates of ferlavirus (Richter et al., 1996).  138
Clark et al. (1979) also demonstrated the presence of neuraminidase  139
activity in ferlavirus. After haemagglutinating chicken and guinea pig  140
erythrocytes with ferlavirus it was observed that these erythrocytes  141
could not be re-agglutinated by ferlavirus, implying that the virus has a  142
receptor destroying enzyme (neuraminidase). 143Page 7 of 49
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Clinical Findings Associated with Infection 144
Ferlaviral infections have been associated with highly pathogenic  145
disease outbreaks (Folsch and Leloup, 1976; Jacobson et al., 1980;  146
Jacobson et al., 1981; Jacobson et al., 1992; Kolesnikovas et al., 2006).  147
Infection has been detected in several snake families: Colubridae, 148
Elapidae, Viperidae, Crotalidae, Boidae and Pythonidae (Jacobson et al.,  149
1997; Ahne et al., 1999b; Oros et al., 2001). One report described the  150
clinical signs associated with ferlaviral infection as being variable, often  151
non-specific, and occasionally subtle (Sand et al., 2004). When clinical  152
signs can be attributed to a particular organ system, they are most  153
commonly localised to the respiratory tract (Jacobson, 2007) but there  154
are also reports about snakes suffering from neurological disease. Table  155
1 outlines the clinical signs reported by various authors. 156
157
In 1991, Lloyd and Flanagan described the clinical manifestations of  158
ferlaviral infection as fitting into three discrete clinical syndromes:  159
snakes affected acutely or peracutely; “poor doers”; and, clinically- 160
healthy animals that shed virus in the face of high antibody titres. These  161
observations were based on clinical experience and were not from a  162
controlled study. 163
Gross Pathology 164
Significant changes that are seen at necropsy are often localised to the  165
respiratory system (Table 2). It is important to note that more than one  166Page 8 of 49
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author has not detected any gross necropsy changes in snakes that  167
were later identified to be infected with ferlavirus. 168
Histopathology 169
There are no histological signs that are pathognomonic for ferlaviral  170
infection (Ritchie, 2006). Instead, a wide range of histopathological  171
findings have been reported that are most commonly attributed to the  172
respiratory and neurological systems (Table 3). Intranuclear or  173
intracytoplasmic viral inclusions may be seen and these should heighten  174
the pathologist’s suspicions of ferlaviral infection (Jacobson, 2007).  175
Ultrastructurally, these inclusions have been shown to consist of strands  176
of viral nucleocapsid (Jacobson, 2007). Although less specific for  177
ferlaviral infection than viral inclusions, proliferative pneumonia and  178
perivascular cuffing in the brain are changes commonly reported in the  179
literature. Jacobson et al. (2001) has noted that inclusion body disease  180
(IBD), mycoplasmosis and infection with orthoreovirus form important  181
rule-outs during an investigation of snakes affected with proliferative  182
pneumonia. 183
184
Through the use of immunohistochemistry, Homer et al. (1995) was  185
able to localise pulmonary infections to the luminal surface and  186
cytoplasm of faveolar epithelium. With a similar purpose, Sand et al. 187
(2004) used in situ hybridisation to locate ferlavirus in a variety of  188
infected organs. Virus was intranuclear in the brain while being  189Page 9 of 49
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intracytoplasmic in hepatocytes, Kupffer cells, pulmonary alveolar  190
[faveolar] macrophages, respiratory epithelial cells and renal tubular  191
epithelial cells. 192
Non-Ferlaviral Microbiological Findings 193
A number of authors have reported on the non-ferlaviral microbiological  194
findings in snakes infected with ferlavirus. Bacterial cultures from  195
various organs have identified several Gram negative bacterial  196
pathogens: Aeromonas, Citrobacter, Escherichia, Enterobacter,  197
Morganella, Proteus, Providencia, Pseudomonas, Salmonella and 198
Serratia (Folsch and Leloup, 1976; Jacobson et al., 1981; Blahak et al.,  199
1991; Jacobson et al., 1992; Homer et al., 1995; Oros et al., 2001;  200
Kolesnikovas et al., 2006; Jacobson, 2007). In one of these studies,  201
fungal elements could not be cultured (Kolesnikovas et al., 2006). It has  202
been suggested that ferlaviral infections may be immunosuppressive,  203
possibly due to lymphoid depletion (Oros et al., 2001), allowing  204
secondary bacterial invaders (Kolesnikovas et al., 2006). So while it is  205
recommended that concurrent complicating bacterial infections be  206
treated as early as possible (Jacobson et al., 1992; Kolesnikovas et al.,  207
2006), antibiotic use may not provide any improvement in already  208
affected snakes (Folsch and Leloup, 1976; Jacobson et al., 1981). 209
210
Papp et al. (2010a) has described the isolation of orthoreoviruses from  211
various organs from four snakes that were positive by PCR for the  212Page 10 of 49
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presence of ferlavirus. In a second study, Abbas et al. (2011) 213
simultaneously detected at least one atadenovirus, an orthoreovirus  214
and a ferlavirus in each of three corn snakes. One of these snakes, a  215
juvenile, was vomiting and displayed dyspnoea before dying. These  216
recent studies form the first reports of mixed viral infections in snakes  217
infected with ferlavirus. 218
Transmission 219
Little is known about ferlaviral transmission. Koch’s postulates were  220
fulfilled after the successful infection (endotracheal inoculation) and re- 221
isolation of ferlavirus in a group of six naïve captive-bred Aruba Island  222
rattlesnakes (Crotalus unicolor) (Jacobson et al., 1997). Another three  223
snakes were sham-inoculated. Ferlavirus was successfully isolated from  224
the lungs of all the snakes that had been inoculated with virus and none  225
of the sham-inoculated snakes. 226
227
Pasmans et al. (2008) states that ferlavirus is easily transmitted through  228
both aerosols and contact, and terraria for individually housed snakes  229
provide little defense against the transmission of ferlavirus. It has also  230
been suggested that ferlavirus may be transmitted from snake to snake  231
by direct contact, respiratory secretions, fomites and ectoparasites  232
(especially mites) (Hernandez-Divers, 2006). In the first outbreak 233
described by Folsch and Leloup (1976), the infection spread from the  234
enclosures closest to the doors in two different rooms. It was  235Page 11 of 49
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hypothesised that spread had occurred either by aerosol or via the  236
keepers. Considering that ferlaviruses have been isolated from the  237
sputum of a rattlesnake (Crotalus durissus terrificus) (Nogueira et al.,  238
2002), oral and cloacal swabs from corn snakes (Pantherophis guttatus)  239
(Abbas et al., 2011) and detected by polymerase chain reaction (PCR) in  240
oral and cloacal swabs (Papp et al., 2010a), it is reasonable to assume  241
that ferlavirus can be transmitted between snakes by both oral  242
secretions and cloacal excretions. To the best of our knowledge,  243
ferlavirus has not been isolated, or detected by PCR, from fomites or  244
ectoparasites. There are currently no reports concerning vertical  245
transmission of ferlavirus (Pasmans et al., 2008). 246
247
The incubation period of ferlavirus in naturally-acquired infections is  248
unknown. There are claims that the incubation period for ferlavirus may  249
be as short as 21 days (Hernandez-Divers, 2006) but will generally  250
exceed 90 days (Hernandez-Divers, 2006; Ritchie, 2006). These claims  251
are not supported by controlled studies. 252
253
The shedding patterns of ferlavirus are unknown (Jacobson and Origgi,  254
2007). Although Lloyd and Flanagan (1991) state that some snakes are  255
capable of shedding virus for an extended period of time, this claim is  256
based on the observation that some snakes have significant  257
haemagglutination inhibition (HI) antibody titres for five months or  258
more while simultaneously “causing” seroconversion in cagemates  259Page 12 of 49
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throughout that time. Ritchie (2006) suggests that asymptomatic  260
seropositive snakes may be persistently-infected shedders while others  261
may have mounted an appropriate immune response and cleared the  262
infection. There are no controlled studies to support any of these claims. 263
Treatment 264
No specific treatment has been identified as being effective against  265
ferlavirus (Marschang and Chitty, 2004). In people, the antiviral drug  266
ribavirin (Virazole®) is sometimes used in the treatment of Measles virus,  267
Respiratory syncytial cell virus and Parainfluenza virus infections  268
(Chakrabarti et al., 2001; Freeman et al., 2004). A drug named BCX 2798  269
that is capable of targeting paramyxoviral neuraminidase has been  270
shown to decrease viral titres in mice infected with a recombinant strain  271
of Sendai virus (Alymova et al., 2005; Watanabe et al., 2009). Neither of  272
these compounds has been tested against ferlavirus either in vitro or in  273
vivo. 274
275
Symptomatic treatment has generally been provided by broad spectrum  276
antibiotics (Kolesnikovas et al., 2006). Bronson and Cranfield (2006) 277
have stated that the survival time of snakes infected with ferlavirus is  278
improved by targeting secondary protozoal and bacterial infections. 279Page 13 of 49
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Prevention 280
Quarantine 281
To prevent the introduction of ferlavirus into a collection it is  282
recommended that new animals are only introduced after a period of  283
quarantine. Recommended lengths of quarantine vary between  284
references (Table 4) but there is a general trend where modern  285
recommendations are for longer periods of time. All of the  286
recommendations are empirical due to the limited information that is  287
available about ferlaviral transmission and environmental viability. 288
289
Various authors have provided specific recommendations about caring  290
for a collection consisting of resident and quarantined animals  291
(Jacobson et al., 1999; Marschang and Chitty, 2004; Ritchie, 2006;  292
Pasmans et al., 2008). During quarantine, agent-specific testing can be  293
used to help determine if a snake has been exposed to, or is infected  294
with, ferlavirus. 295
Vaccination 296
There have been only two reported attempts to develop a ferlavirus  297
vaccine. In one study, a sustained and significant concentration of  298
circulating anti-ferlavirus antibodies could not be elicited in a group of  299
western diamondback rattlesnakes (Crotalus atrox) following  300
inoculation with an inactivated (killed) strain of ferlavirus (Jacobson et  301
al., 1991). Vaccinated snakes were not challenged with unattenuated  302Page 14 of 49
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virus. Mayr et al. (2000) has suggested that cell culture-adapted  303
ferlaviral isolates could be used in the production of live vaccines but in  304
a brief and limited report of a vaccine trial using a modified-live isolate  305
of ferlavirus, one snake died and another suffered severe illness (Lloyd  306
and Flanagan, 1991). 307
Ferlavirus in Non-Captive Free-Ranging Snakes 308
Only a few reports have described ferlavirus in wild snakes. A survey of  309
ten free-ranging anacondas (Eunectes murinus) from Venezuela involved  310
serological testing against a number of pathogens, including ferlavirus  311
(Calle et al., 2001). Ferlaviral-specific antibody titres were negative by  312
haemagglutination inhibition (HI) in all snakes. 313
314
In two separate studies Allender et al. (2006; 2008) screened wild- 315
caught eastern massasauga rattlesnakes (Sistrurus catenatus catenatus)  316
for the presence of anti-ferlavirus antibodies using HI. All 20 snakes  317
from the 2006 study were seropositive against two ferlaviral isolates at  318
one diagnostic laboratory. In the 2008 study, 26 snakes were tested and  319
zero to 26 of them were seropositive depending on the isolate that was  320
used as antigen and the laboratory that the samples were sent to. These  321
discordant antibody results on a standardised sample set highlighted  322
the variability that existed between diagnostic laboratories. Additional  323
testing that is capable of detecting ferlavirus (e.g. virus isolation,  324
polymerase chain reaction, in situ hybridisation or electron microscopy)  325Page 15 of 49
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was not performed. 326
Ferlavirus in Non-Snake Reptilian Hosts 327
Lizards 328
Most of the paramyxoviruses that have been described in lizards have  329
not been associated with overt disease. A paramyxovirus was isolated  330
from a false tegu (Callopistes maculatus) in 1988 (Ahne and Neubert,  331
1991) that was later identified as a ferlavirus by sequence analysis  332
(Ahne et al., 1999b). Similarly, a paramyxovirus was isolated from the  333
mouth of an apparently healthy monitor lizard (Varanus prasinus) that  334
was part of a reptile collection that had suffered an outbreak of  335
ferlavirus in its snake population (Gravendyck et al., 1998). 336
337
In a serological survey of lizards, Gravendyck et al. (1998) collected  338
serum from 49 healthy free-ranging Honduran Island iguanas  339
(Ctenosaura bakeri, C.similis and Iguana iguana rhinolopha) to look for  340
evidence of paramyxoviral and reoviral infections. Using a reptilian  341
paramyxovirus isolated from a monitor lizard (Varanus prasinus) as  342
antigen, 41% of all 49 serum samples had antibodies that could be  343
detected by virus neutralisation. 34 serum samples were tested against  344
this paramyxovirus isolate by haemagglutination inhibition and only  345
three (9%) had antibody titres of ≥20 (maximum titre was 32). The  346
authors could not isolate any viruses from pharyngeal and cloacal swabs  347
from these lizards. In a similar study, Marschang et al. (2002) tested 30  348Page 16 of 49
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wild-caught Mexican lizards (Xenosaurus grandis, X.platyceps and  349
Abronia graminea) for exposure to paramyxovirus and reovirus: 30 were  350
tested by virus isolation and 23 were tested by virus neutralisation  351
(reovirus) and HI (paramyxovirus). Anti-ferlavirus antibodies were  352
detected in four animals representing all three species but significantly,  353
a ferlavirus was isolated from the cloacal swab of X.platyceps. The  354
results of this report were unable to clarify the clinical significance of  355
finding ferlavirus and ferlaviral antibodies in these species. 356
357
Lloyd et al. (2005) serologically tested the lizard population of a  358
zoological park where the resident snake collection had a history of  359
paramyxovirus-associated disease. In total, 59 lizards (from 12 families)  360
were tested for the presence of ferlavirus-specific antibodies by  361
haemagglutination inhibition (HI). All the lizards, except one, were  362
clinically normal. Seven lizards had HI titres that were considered  363
positive (≥16) for exposure to ferlavirus. These seven positive animals  364
were then retested 105 days later and six of them had either  365
maintained or increased their antibody titres. The authors concluded  366
that the six animals had active infection, were repeatedly exposed to  367
antigen or were in a carrier state. In another study, ferlavirus exposure  368
was serologically assessed in 32 geckos (Gecko monarchus and Gehyra  369
mutilata) that free-roamed the grounds of a zoological park (Kummrow 370
et al., 2004). Blood was pooled from these small geckos and 70% of  371
pooled blood samples tested positive for ferlavirus exposure by HI. The  372Page 17 of 49
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authors speculate that the geckos may have a role as vectors for this  373
virus but more detailed investigations would be necessary to elucidate  374
this idea further. 375
376
There are only two reports where a paramyxovirus was associated with  377
mortality in a lizard (Jacobson et al., 2001; Boyer et al., 2005). Three  378
separate epidemics of ferlavirus were seen between 1998 and 1999 in  379
caiman lizards (Dracena guianensis) that had been imported into the  380
USA from Peru (Jacobson et al., 2001). Many individuals were found  381
dead or were anorexic upon arrival. Histopathology showed severe  382
heterophilic and histiocytic pneumonia and ferlavirus was detected in  383
tissue sections by immunohistochemistry. A virus was isolated and  384
electron microscopic examination confirmed the presence of a  385
paramyxovirus. In the second report, paramyxovirus-like particles were  386
seen by electron microscopy in the respiratory tract of a Thai water  387
dragon (Physignathus concinus) (Boyer et al., 2005). Histological  388
assessment revealed a proliferative interstitial pneumonia and  389
eosinophilic intracytoplasmic inclusions of the pneumocytes and  390
pancreatic ductular epithelium. DNA probes could not detect a reptilian  391
paramyxovirus in paraffin-embedded sections. 392
Chelonians 393
In 1983, Jackson and Needham reported on the discovery of anti-Sendai  394
virus haemagglutination inhibition (HI) titres of up to 256 in 34 tortoises  395Page 18 of 49
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from three species: Testudo graeca (Greek tortoise), T.hermanni  396
(Herman’s tortoise) and Geochelone elegans (Indian star tortoise).  397
Seven of these 34 tortoises were showing signs of rhinitis at the time of  398
blood sampling. There was little correlation between anti-Sendai virus  399
HI titre and the presence of clinical signs. The authors did not attempt  400
to isolate a paramyxovirus from any of these tortoises. In another study,  401
a collection of Mediterranean tortoises (Testudo graeca and T.hermanni)  402
were imported from Turkey to Switzerland and upon arrival many were  403
found to have a viral dermatitis (Zangger et al., 1991). Light microscopy  404
revealed intracytoplasmic inclusions in the stratum germinativum and  405
under electron microscopy, paramyxovirus-like particles were identified. 406
407
In 1990, Oettle et al. (1990) reported on the death of 31 out of 83  408
African tortoises from four species: Psammobates tentorius (tent  409
tortoise), Homopus areolatus (beaked cape tortoise), Chersina angulata  410
(bowsprit tortoise) and Geochelone pardalis (leopard tortoise). Affected  411
tortoises displayed a wide range of clinical signs and pathological  412
changes but anorexia, progressive lethargy, severe ascites, hepatosis,  413
pneumonia and necrotic pseudomembranous stomatitis were seen  414
most commonly. Paramyxovirus-like inclusions were identified under  415
light microscopy in oesophageal cells from one tortoise. It is likely that a  416
range of disease processes featured in this outbreak and whether a  417
paramyxovirus was present, and if so, the role it played, is unclear. 418
419Page 19 of 49
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In 1993, Witte found three out of 128 tortoises from ten different  420
collections revealed antibody titres against a snake paramyxovirus.  421
Titres were 1:16 in two Russian tortoises (Agrionemys [Testudo]  422
horsfieldii) and 1:32 in a Greek tortoise (Testudo graeca). 423
424
In 1999, a ferlavirus was isolated from a Hermann’s tortoise (Testudo  425
hermanni) suffering from pneumonia (Marschang et al., 2009). The  426
identity of this ferlavirus was confirmed by sequence analysis. More  427
recently, several different ferlaviruses were detected by PCR from  428
various organs of a leopard tortoise (Geochelone pardalis babcocki)  429
suffering from respiratory distress (Papp et al., 2010b). There were large  430
amounts of mucopurulent discharge from its nares and mouth and on  431
necropsy, the lungs were bilaterally consolidated and filled with thick  432
serous exudate. The ferlaviruses detected by PCR could not be isolated  433
into cell culture. 434
435
In the most recent study on ferlaviruses in tortoises, tortoise plasma  436
was screened for antibodies against ferlaviruses using  437
haemagglutination inhibition testing. Antibodies were found in several  438
tortoise species from several European countries  (Rösler et al., 2013). 439
Crocodiles 440
Using electron microscopy, paramyxoviruses have been found in the  441
faeces of Nile crocodiles (Crocodylus niloticus) that had been fed  442Page 20 of 49
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chickens from a farm that were having an outbreak of Newcastle  443
disease virus (Huchzermeyer et al., 1994). This study also provided  444
limited information about a paramyxovirus that was seen in the faeces  445
of a crocodile not fed a diet of chickens. 446
447
Only a small proportion of the reports about ferlavirus in non-snake  448
reptiles show a strong association between disease and infection with  449
this pathogen but there is insufficient data to ignore the possibility that  450
lizards, chelonians and maybe even crocodiles, play important roles as  451
reservoir hosts for ferlavirus. This could have important implications  452
when attempting to eradicate ferlavirus or prevent its introduction in  453
collections that house snakes with other reptiles. 454
Zoonotic Potential 455
Ahne and Mayr (2000) investigated the capability of ferlavirus to infect  456
human blood mononuclear cell culture at the virus-permissive  457
temperature of 28
0C. Viral replication could not be detected in this cell  458
line. Potgieter et al. (1987) successfully cultured a paramyxoviral isolate  459
from a snake in hamster kidney cells at 37
0C but this study found that  460
the highest haemagglutination titre, the greatest likelihood to grow in  461
cell culture and the most significant cytopathic effects were seen when  462
the isolate had been grown at 30
0C. Under the conditions described by  463
other authors, it was found that ferlavirus did not replicate at 37
0C  464
(Clark et al., 1979; Blahak, 1995; Ahne et al., 1999a; Ahne and Mayr,  465Page 21 of 49
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2000). Clark et al. (1979) comprehensively investigated the susceptibility  466
of mice to infection with ferlavirus and could not detect any clinical or  467
histological evidence of disease. Based on this information it would  468
seem unlikely that ferlavirus would pose a serious zoonotic risk to  469
human health. 470
Diagnostic Tests 471
Virus Isolation 472
Tissue samples and oral and cloacal swabs are often used to isolate  473
viruses from infected reptiles (Marschang and Chitty, 2004). Table 5  474
provides a summary of the techniques that have been used to isolate  475
paramyxoviruses from reptiles. The cytopathic effect associated with  476
infection from reptilian paramyxoviruses has been described by a  477
number of authors (Table 6). Syncytial cell formation and cell lysis are  478
commonly reported. The time taken for CPE to emerge varies markedly  479
between references: from only 24 to 36 hours (Ahne et al., 1987) to  480
requiring serial passage (Jacobson et al., 1980). The successful isolation  481
and/or propagation of reptilian paramyxoviruses using embryonated  482
eggs have been reported (Clark et al., 1979; Ahne et al., 1999a). Similar  483
attempts by other authors were unsuccessful (Potgieter et al., 1987;  484
Manvell et al., 2000) (Table 5). 485
Electron Microscopy 486
Many authors have utilised transmission electron microscopy (TEM) to  487Page 22 of 49
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identify reptilian paramyxoviruses (Lunger and Clark, 1978; Clark et al.,  488
1979; Jacobson et al., 1980; Jacobson et al., 1981; Ahne et al., 1987;  489
Potgieter et al., 1987; Richter et al., 1996; Jacobson et al., 1997; Manvell 490
et al., 2000; Franke et al., 2001; Jacobson et al., 2001; West et al., 2001).  491
Ferlaviruses are medium-sized, have spiked envelopes and can be  492
spherical to pleomorphic in morphology (Jacobson and Samuelson,  493
2007). The nucleocapsid of a paramyxovirus forms the core of the virion  494
and has a distinct “herring bone” appearance (Ahne and Mayr, 2000).  495
Spherical and filamentous forms of ferlavirus have been seen budding  496
from infected cells (Jacobson et al., 1997). 497
498
Inclusion bodies have been identified under light microscopy in snake  499
tissue infected with ferlavirus (Jacobson et al., 1981; Potgieter et al.,  500
1987; Homer et al., 1995; Jacobson et al., 1997; West et al., 2001).  501
Ultrastructural assessment has shown these inclusions to be comprised  502
of nucleocapsid strands (Jacobson et al., 1981; Jacobson et al., 1997). 503
Haemagglutination (HA) Assays 504
Large quantities of virus are needed for macroscopic haemagglutination  505
so this method is considered to be relatively insensitive (Quinn et al.,  506
2002). In one study, ferlavirus-infected tissue homogenates did not  507
haemagglutinate chicken erythrocytes but ferlavirus could be isolated  508
onto viper heart cells and be detected by polymerase chain reaction  509
(Kolesnikovas et al., 2006). Only after replication in viper heart cells,  510Page 23 of 49
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could haemagglutination be detected. Studies comparing the lower  511
limits of detection of haemagglutination to other diagnostic tests, such  512
as polymerase chain reaction, do not exist. 513
514
Haemagglutination Inhibition (HI) 515
Haemagglutination inhibition (HI) has been used widely as a serological  516
test for the detection of exposure to ferlavirus (Jacobson et al., 1981;  517
Potgieter et al., 1987; Jacobson et al., 1991; Jacobson et al., 1992;  518
Brousset et al., 1994; Blahak, 1995; Richter et al., 1996; Jacobson et al.,  519
1997; Gravendyck et al., 1998; Manvell et al., 2000; Calle et al., 2001;  520
Jacobson et al., 2001; Marschang et al., 2002; Lloyd et al., 2005;  521
Allender et al., 2006; Allender et al., 2008) and is offered commercially  522
by several diagnostic laboratories (Table 7). 523
524
Various vertebrate erythrocytes have been compared to each other in  525
their ability to haemagglutinate three isolates of ferlavirus (Richter et al.,  526
1996). Chicken and guinea pig erythrocytes reliably haemagglutinated  527
these three isolates and outperformed sheep, human type-O and rabbit  528
erythrocytes. Many, if not all, of the laboratories that offer HI  529
commercially utilise chicken or guinea pig erythrocytes as markers of  530
ferlavirus-induced haemagglutination (Allender et al., 2008). 531
532
There is disagreement in the literature about the titres that should be  533Page 24 of 49
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considered positive for exposure to ferlavirus. Titres of greater than 10  534
(Jacobson et al., 1992) and 16 (Pasmans et al., 2008) have been  535
reported but it has also been suggested that less than 20 is negative,  536
between 40 and 80 is suspect and greater than 80 is positive (Jacobson  537
and Origgi, 2007). 538
539
Pasmans et al. (2008) recommends that paired samples, eight weeks  540
apart, be taken to determine if a snake has a rising antibody titre. A  541
rising titre may indicate current exposure to ferlavirus, while a  542
“positive” titre that does not increase (i.e. stays the same or decreases)  543
may be indicative of previous exposure (Jacobson and Origgi, 2007). HI  544
assays quantify the ability of serum or plasma to inhibit macroscopic  545
haemagglutination without delineating the contributions to this  546
inhibition that were made by immunoglobulin M (IgM) and IgY (the  547
reptilian equivalent of IgG). In addition to this, controlled experiments  548
that were able to identify the antibody titres at several time points  549
during and after antigen exposure do not exist. So conclusions drawn  550
from rising, falling or unchanged anti-ferlavirus HI titres may not always  551
be reliable. Despite these limitations, reports do exist that provide  552
useful information about the HI titres that were seen during a  553
controlled transmission study and also naturally occurring outbreaks of  554
ferlavirus infection. 555
556
An experimental transmission of ferlavirus in Aruba Island rattlesnakes  557Page 25 of 49
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(Crotalus unicolor) forms the only study where ferlavirus was inoculated  558
into snakes under controlled conditions (Jacobson et al., 1997). In this  559
study, HI titres were only assessed at the time of death. The last death  560
occurred 22 days after inoculation. No snake had developed an antibody  561
response that could be detected by HI. 562
563
In an outbreak of ferlavirus in a zoological collection, Jacobson et al.  564
(1992) tested 31 snakes for the presence of anti-ferlavirus antibodies by  565
HI. Twelve snakes showed positive titres (greater than 10) and these  566
animals were then retested a number of times over the next year. Many  567
cases showed high titres (5,120 to greater than 20,480) that decreased  568
to low titres (below 100) over three to seven months. 569
570
In another outbreak of ferlavirus in reptiles, this time a collection of  571
caiman lizards (Draecena guianensis), HI testing was performed on  572
surviving animals several months after a ferlavirus had been isolated  573
from dead animals (Jacobson et al., 2001). From 17 animals tested,  574
there were seven titres of less than or equal to 20 and ten titres were  575
between 20 and 180. 576
577
An HI titre is complicated by a long list of variables: the antibody’s  578
affinity to the antigen, the integrity of the antigen being used, the  579
availability of antibody in the serum, the preservation of the sample and  580
lastly, the host’s immune response, which itself is influenced by  581Page 26 of 49
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temperature, the season, nutritional status, antigen concentration,  582
route of inoculation, frequency of exposure to the antigen and the type  583
of antigen (Lloyd et al., 2005). The influences that these factors have on  584
an HI titre have not been investigated in a controlled experiment and so  585
the consideration that should be made to each of these factors can only  586
be speculated. Some zoological collections and private institutions  587
require negative ferlavirus titres during quarantine before a snake is  588
released into the main collection (Allender et al., 2008) and the  589
difficulties in interpreting HI titres places the decision-making  590
veterinarian in a difficult position. 591
592
According to Lloyd et al. (2005), if there is a serological unrelatedness  593
between the ferlavirus that has been used as antigen in an HI assay and  594
the ferlavirus the animal has been exposed to, negative HI titres may  595
occur. For this reason, other authors have recommended that two  596
different viral isolates are used as the antigen source to accommodate  597
serological differences that might exist between ferlavirus strains  598
(Pasmans et al., 2008). In a study of 60 snake serum samples that were  599
being tested by HI using two different strains of ferlavirus as antigens,  600
considerable variation in HI titre was seen between the two antigens  601
but most snakes that were considered to be positive, were positive  602
using either antigen (Kania et al., 2000). 603
604
In contrast to the findings of Kania et al. (2000), Allender et al. (2008) 605Page 27 of 49
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found there was considerable variation in the HI titres of 26 wild-caught  606
eastern massasaugas (Sistrurus catenatus catenatus) when analysed at  607
three American commercial laboratories, which between them, utilise  608
four different isolates of ferlavirus as antigen. Against two antigens, 100  609
percent of plasma samples were positive, 56 percent were positive  610
against the third and none were positive against the last. The diagnostic  611
implications of these results are unknown but making decisions based  612
on HI serology may be problematic. 613
Non-haemagglutination Inhibition Antibody Assays 614
Only two reports describe the detection of anti-ferlaviral antibodies  615
using non-haemagglutination inhibition assays. Serum neutralisation  616
was used by Gravendyck et al. (1998) to detect antibodies against a  617
reptilian paramyxovirus (isolated from a monitor lizard, Varanus  618
prasinus) in 49 free-ranging Honduran Island iguanas (Ctenosaura bakeri,  619
C.similis and Iguana iguana rhinolopha). It was found that 41% of the  620
serum samples had antibodies that could be detected by virus  621
neutralisation. This compares to 9% (out of a subset of 34 animals) that  622
had haemagglutination inhibition (HI) antibody titres of ≥20 (maximum  623
titre was 32). In the second study, an enzyme-linked immunosorbent  624
assay (ELISA) was compared to HI for the detection of exposure to  625
ferlavirus (Kania et al., 2000). Although there were titre differences  626
between these two diagnostic tests, overall, there was agreement as to  627
whether a sample was positive or negative. 628Page 28 of 49
Accepted Manuscript
Immunohistochemistry (IHC) 629
Immunohistochemistry (IHC) requires the availability of animal-derived  630
polyclonal or monoclonal antibodies that are specific to the virus under  631
investigation (Sand et al., 2004). The use of polyclonal antibodies makes  632
this test difficult to standardise between laboratories (Homer et al.,  633
1995). 634
635
The detection of ferlavirus by IHC has been reported by various authors.  636
Homer et al. (1995) inoculated rabbits with ferlavirus to produce a  637
source of anti-ferlavirus polyclonal antibodies. These antibodies were  638
then used to immunohistochemically identify ferlavirus antigen in  639
formalin-fixed paraffin-embedded tissues. This study demonstrated that  640
standard formalin-fixation practices did not prevent the identification of  641
ferlavirus in infected tissues. However, fixation times were not always  642
listed. Since this first report, IHC has been used to detect ferlavirus  643
antigen in ferlavirus-infected Vero cells (Richter et al., 1996),  644
experimentally-inoculated Aruba Island rattlesnakes (Crotalus unicolor)  645
(Jacobson et al., 1997), a caiman lizard (Draecena guianensis) (Jacobson 646
et al., 2001), six snakes from the Canary Islands (Oros et al., 2001) and  647
three pit vipers (Bothrops alternatus) from Brazil (Kolesnikovas et al.,  648
2006). 649
In Situ Hybridisation (ISH) 650
Two advantages that in situ hybridisation (ISH) has over IHC, is that  651Page 29 of 49
Accepted Manuscript
biologically-derived polyclonal or monoclonal antibodies are not needed  652
and that viral transcripts can be detected (Sand et al., 2004). Using  653
oligonucleotides as probes, Sand et al. (2004) were able to identify  654
segments of the ferlavirus haemagglutinin-neuraminidase attachment  655
gene (HN) in the tissue sections of 11 out of 14 snakes that had  656
histopathological findings that were consistent with a ferlavirus  657
infection. The 14 samples were then tested by polymerase chain  658
reaction (PCR) and the same 11 samples were positive. No further  659
investigations of the three negative results were reported. In another  660
report, West et al. (2001) used a generic avian paramyxovirus probe to  661
detect ferlavirus in the brain of a Boelen’s python (Morelia boeleni) with  662
neurological signs. 663
Polymerase Chain Reaction (PCR) 664
As mentioned in the previous section on in situ hybridisation (ISH), Sand  665
et al. (2004) used PCR to identify ferlaviral RNA in FFPE tissues. Primer  666
sequences that target the attachment gene (HN) were designed that  667
produce relatively small amplicons: 153 nucleotides. 668
669
PCR is dependent on an adequate quantity and quality of viral RNA  670
being present in the sample. In a hypothetical example where a cloacal  671
swab was tested by PCR and the swab was collected from a snake  672
infected with ferlavirus that is not shedding ferlavirus into its cloaca, the  673
PCR result will be negative. The shedding pattern of ferlavirus is not  674Page 30 of 49
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known (Jacobson and Origgi, 2007), so PCR results in live snakes that are  675
negative may not always be accurate representations of the animal’s  676
disease status.  677
678
In 1999, primer sequences were designed and then successfully used for  679
the detection of the polymerase (L) gene of ferlavirus (Ahne et al.,  680
1999b). This L gene primer set has been used for nucleic acid detection  681
by several authors (Ahne et al., 1999b; Franke et al., 2001; Nogueira et  682
al., 2002; Marschang et al., 2009; Papp et al., 2010a; Papp et al., 2010b; 683
Abbas et al., 2011) and diagnostic laboratories (Table 7). In contrast to  684
this, the haemagglutinin-neuraminidase (HN) gene has been targeted by  685
other investigators (Sand et al., 2004; Kolesnikovas et al., 2006). Kurath  686
et al. (2004) reported the order of conservation between paramyxoviral  687
proteins (most conserved to least conserved): V-carboxy domain > L >  688
M/F > N/HN > V > P. In agreement with this, Kindermann et al. (2001) 689
found the L gene, from a selection of ferlaviruses, to be more conserved  690
than the HN gene. 691
692
In one study, a PCR targeting the HN gene was performed on 47 clinical  693
samples (swabs, organs) that had previously been determined to be  694
positive for ferlavirus by an L gene PCR (Papp et al., 2010a). Only 34%  695
were positive when tested with the HN gene PCR. Because this study  696
first screened samples with the L gene PCR, there was no opportunity  697
that a sample could be discovered that was positive by the HN gene PCR  698Page 31 of 49
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and negative by the L gene PCR. In another study, Kolesnikovas et al. 699
(2006) used an HN gene primer set (Ahne et al., 1999b) to successfully  700
amplify ferlavirus from cell culture supernatant and infected tissues.  701
Some tissue samples were negative using this primer set but these 702
results were not pursued. Considering several reports have been able to  703
detect ferlaviruses using an L gene PCR but not with HN, F and/or U  704
gene PCRs (Ahne et al., 1999b; Franke et al., 2001; Marschang et al.,  705
2009; Papp et al., 2010a), it seems reasonable to target the L gene in  706
preference to other genes. 707
708
Not all authors have used the primer sets designed by Ahne et al.  709
(1999b). In a retrospective study of 22 snakes from the Netherlands that  710
died with histological findings consistent with ferlavirus infection, ten  711
were positive for ferlavirus using newly designed primers (Kik et al.,  712
2004). Other studies have used novel degenerate primers to target the  713
fusion (F) (Franke et al., 2001; Franke et al., 2006) and “unknown” (U)  714
(Marschang et al., 2009) genes of ferlavirus but neither primer set has  715
been used diagnostically. 716
Commercially Available Diagnostic Tests 717
The diagnostic tests for ferlavirus that are available to the clinical  718
practitioner are restricted to haemagglutination inhibition (HI),  719
polymerase chain reaction (PCR) and virus isolation (Table 7). To the  720
best of our knowledge, these tests are only offered on a commercial  721Page 32 of 49
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basis in Europe, the United States of America, and Australia. 722
Sunshine virus 723
In 2008, tissue and serum samples were collected following an outbreak  724
of neurorespiratory disease in an Australian collection of 70 pythons. A  725
syncytial-cell forming virus was isolated and using Illumina® high- 726
throughput sequencing, the virus was identified as a novel  727
paramyxovirus (Hyndman et al., 2012a). The virus was named Sunshine  728
virus after the geographical origin of the first isolate: the Sunshine Coast  729
of Queensland, Australia. This virus represents the first paramyxovirus  730
to be identified from a reptile that was not a ferlavirus. This virus has  731
not been detected outside of Australia although testing thus far has  732
been limited. 733
734
A set of PCR primers has since been designed that has been able to  735
detect Sunshine virus in swabs and fresh and formalin-fixed paraffin- 736
embedded tissues (Hyndman et al., 2012b). Sunshine virus has so far  737
been detected in black-headed pythons (Aspidites melanocephalus),  738
woma pythons (A. ramsayi), spotted pythons (Antaresia maculosa) and  739
carpet pythons (Morelia spilota spp. and M.bredli). Clinical signs  740
associated with Sunshine virus, like ferlavirus, are non-specific (e.g.  741
lethargy, inappetance) and/or neurorespiratory in origin. Gross  742
pathology is usually unremarkable. Histopathology reliably exhibits  743
hindbrain white matter spongiosis and gliosis with extension to the  744Page 33 of 49
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surrounding grey matter and neuronal necrosis is evident in severe  745
cases. A mild bronchointerstitial pneumonia is seen in some snakes. In  746
contrast to ferlavirus, which is most often detected in lung (Papp et al.,  747
2010a), Sunshine virus was detected most often in brain. 748
Conclusion 749
Over the last 40 years, more than 50 papers have been published about  750
the paramyxoviruses that infect reptiles. The majority of these are  751
concerned with the ferlaviruses that infect snakes but recently, a  752
diverse paramyxovirus that infects snakes, named Sunshine virus, has  753
been described. Outbreaks of ferlavirus have been associated with  754
significant morbidity and mortalities, and so it is important that  755
herpetologists and veterinarians that work with reptiles are aware of  756
the biology of these viruses and the clinical signs and pathological  757
findings that are associated with infection. There are still important  758
gaps in the knowledge concerning these viruses and their associated  759
infections. For example, the incubation periods and shedding kinetics of  760
the paramyxoviruses from reptilian hosts, and the survivability of the  761
virus once outside the host, are all poorly understood and as  762
consequences, choosing appropriate quarantine periods, proper  763
sampling times and suitable sample types is problematic. It is our hope  764
that this review will help future researchers of this area identify these  765
knowledge gaps so they may contribute to this field as effectively as  766
possible. 767Page 34 of 49
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Clinical Sign Reference
Nonspecific
Anorexia (Jacobson et al., 1992; Manvell et al., 
2000; Kolesnikovas et al., 2006)
Regurgitation (occasional) (Jacobson et al., 1981; Jacobson et al., 
1992; Kolesnikovas et al., 2006)
Mucoid diarrhoea or malodorous 
stools
(Jacobson et al., 1981; Jacobson et al., 
1992; Kolesnikovas et al., 2006)
Lethargy/Moribund (Folsch and Leloup, 1976; Ahne et al., 
1987)
Sudden death (Jacobson et al., 1981; Jacobson et al., 
1997; Marschang et al., 2009; Papp et al., 
2010)
Respiratory
Not seen (Jacobson et al., 1992; West et al., 2001)
Not described further (Blahak, 1995; Kolesnikovas et al., 2006; 
Marschang et al., 2009)
Brown to haemorrhagic discharge 
from nostrils and/or trachea or in 
oral cavity
(Jacobson et al., 1981; Jacobson et al., 
1997)
Stridor and/or respiratory noise (Manvell et al., 2000)
Pneumonia (Blahak et al., 1991; Nogueira et al., 2002; 
Papp et al., 2010)
Clear mucus in mouth (Potgieter et al., 1987)
Clear nasal discharge (Manvell et al., 2000)
Mouth gaping (Folsch and Leloup, 1976; Jacobson et al., 
1981)
Neurological
Not described further (Blahak, 1995; Papp et al., 2010)
Complete flaccid paralysis (West et al., 2001)
Decreased cutaneous sensation (West et al., 2001)
Head tremors (Jacobson et al., 1980; Jacobson et al., 
1992; Kolesnikovas et al., 2006)
Abnormal 
posturing/disequilibrium i.e. 
opisthotonus (star gazing) or 
inability to right itself
(Folsch and Leloup, 1976; Jacobson et al., 
1980; Blahak et al., 1991; Jacobson et al., 
1992; Kolesnikovas et al., 2006; Papp et 
al., 2010)
Table 1 Clinical signs associated with ferlaviral infection. Only the references  1032
that report on original data are included here. 1033
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Gross Pathology Reference
None (Jacobson et al., 1997; Kolesnikovas et al., 
2006)
Pulmonary congestion or 
oedema
(Folsch and Leloup, 1976; Potgieter et al., 
1987; Oros et al., 2001; Kolesnikovas et al., 
2006; Jacobson, 2007)
Haemorrhagic pneumonia (Jacobson et al., 1992; Jacobson et al., 1997; 
Oros et al., 2001; West et al., 2001)
Blood in oral cavity or free in 
coelom
(Jacobson et al., 1997; Jacobson, 2007)
White nodules on liver (Jacobson et al., 1992)
Mucoid or caseous exudate in 
the lung
(Jacobson et al., 1980; Jacobson et al., 1981; 
Blahak et al., 1991)
Diffuse to focal accumulations of 
caseous necrotic debris in 
pulmonary tissue
(Jacobson et al., 1992; Oros et al., 2001)
Table 2 Gross pathological changes seen associated with ferlaviral infection. 1035
1036
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Histopathological Change Reference
Respiratory
Moderate to diffuse amounts of 
cellular debris and exudate filling 
airways
(Jacobson et al., 1980; Jacobson et al., 
1981)
Varying amounts of mixed 
inflammatory cells in the 
interstitium
(Jacobson et al., 1980; Jacobson et al., 
1981; Potgieter et al., 1987; Jacobson et 
al., 1992; Jacobson et al., 1997; Oros et 
al., 2001; West et al., 2001; Kolesnikovas
et al., 2006; Jacobson, 2007)
Gram negative microorganisms 
seen
(Homer et al., 1995; Oros et al., 2001; 
Jacobson, 2007)
Hyperplastic alveolar [faveolar] 
cells
(Potgieter et al., 1987; Homer et al., 1995; 
Jacobson et al., 1997; Oros et al., 2001; 
Jacobson, 2007)
Thickened pulmonary septae (Homer et al., 1995; Jacobson et al., 1997; 
Jacobson, 2007)
Hyperplasia and often 
hypertrophied epithelium
(Jacobson et al., 1981; Homer et al., 
1995)
Small numbers of pale eosinophilic 
intracytoplasmic (or not described) 
inclusions
(Jacobson et al., 1981; Potgieter et al., 
1987; Blahak et al., 1991; Homer et al., 
1995; Jacobson et al., 1997)
Giant cell formation (Homer et al., 1995; Kolesnikovas et al., 
2006)
Lesion severity decreases from 
cranial to middle to caudal lung 
area*
(Jacobson et al., 1997)
Neurological
§
Eosinophilic intracytoplasmic 
inclusion bodies
(West et al., 2001)
Demyelination and degeneration of 
axon fibers
(Jacobson et al., 1980)
Multifocal neuronal degeneration (West et al., 2001)
Lymphohistiocytic neuritis of 
oesophagus
(West et al., 2001)
Moderate axonal sheath ballooning (Jacobson et al., 1980)
Multifocal gliosis (Jacobson et al., 1980)
Perivascular cuffing in the brain (Jacobson et al., 1980; West et al., 2001; 
Jacobson, 2007)
Other
Intracytoplasmic inclusion bodies 
in the liver
(Blahak et al., 1991)
Pancreatitis and/or pancreatic 
necrosis and/or pancreatic fibrosis
(Jacobson et al., 1980; Jacobson et al., 
1992; Kolesnikovas et al., 2006; Jacobson, 
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Pancreatitic giant cell formation (Kolesnikovas et al., 2006)
Pyogranulomatous hepatitis (Jacobson et al., 1992)
Gram negative infections seen in 
many organs
(Jacobson et al., 1992)
Table 3 Histopathological changes seen associated with ferlaviral infection. 1038
*These findings were in snakes that were experimentally infected with  1039
ferlavirus by endotracheal inoculation. 
§Brain was not examined histologically  1040
in Jacobson et al. (1981), Potgieter et al. (1987), Jacobson et al. (1992), Homer  1041
et al. (1995) or Jacobson et al. (1997). It is unclear whether the brain was  1042
examined in Oros et al. (2001) and Kolesnikovas et al. (2006). 1043
1044
1045
1046Page 45 of 49
Accepted Manuscript
1046
Quarantine Time Reference
At least 30 days (Jacobson et al., 1980)
Minimum of 60 days (Lloyd and Flanagan, 1991)
Minimum of 60-90 days (Bronson and Cranfield, 2006)
Up to 90 days (Gillespie, 2006)
90 days (Pasmans et al., 2007)
Minimum of 90 days for animal raised in 
captivity
(Ritchie, 2006)
Minimally 90 days in a clinically healthy 
collection
(Jacobson et al., 1992; Marschang 
and Chitty, 2004)
At least two months since the last death 
in an affected collection
(Jacobson et al., 1992)
Minimum of three months with serology 
done at beginning and end
(Jacobson et al., 1999)
Four months (Hernandez-Divers, 2006)
Six months or 180 days (Keeble, 2004; Ritchie, 2006; 
Rossi, 2006)
Table 4 The various quarantine periods that are recommended in the ferlaviral  1047
literature. 1048
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Virus Isolation Techniques Reference
Successful attempts
Sputum inoculated directly onto Vero cells (Nogueira et al., 2002)
Fulfilling Koch’s postulates: Vero cell-adapted 
ferlavirus was transmitted to naïve snakes and 
then lung homogenates were recovered at 
necropsy and used to reisolate ferlavirus onto 
Vero cells
(Jacobson et al., 1997)
Lung suspension inoculated onto fathead 
minnow skin cells (FHM, a piscine cell line), 
hamster kidney cells (BHK-21), swine testicular 
cells (ST), Vero cells and primary bovine 
turbinate cells (BTU)
(Potgieter et al., 1987)
Lung suspension inoculated into embryonated 
snake eggs and then subcultured onto nine 
reptilian and four mammalian cell lines
(Clark et al., 1979)
Pooled and/or individual snake organs 
inoculated onto monolayer of VH2 and/or IgH2 
cells
(Jacobson et al., 1980; 
Jacobson et al., 1981; 
Ahne et al., 1987; Blahak, 
1994; Homer et al., 1995; 
Kolesnikovas et al., 2006; 
Papp et al., 2010a; Abbas
et al., 2011)
Various lizard organs inoculated onto VH2 and 
TH1 cells. After eight passages in TH1 cells, was 
adapted to Vero cells
(Jacobson et al., 2001)
Ferlavirus replicating in VH2 cells adapted to 
Vero cells
(Blahak, 1995; Richter et 
al., 1996; Mayr et al., 
2000)
Ferlavirus replicating in IgH2 cells adapted to 
Vero cells
(Richter et al., 1996; Mayr
et al., 2000)
Ferlavirus replicating in IgH2 cells adapted to 
chicken embryo fibroblasts (LSCC-H32) and 
embryonated chicken eggs
(Ahne et al., 1999)
Ferlavirus replicating in VH2 cells adapted to 
chicken embryo fibroblasts
(Blahak, 1994)
Ferlavirus replicating in VH2 cells adapted to 
Madin Darby bovine kidney cells (MDBK) and 
rabbit kidney cells (RK-13)
(Blahak, 1995)
Lung suspension inoculated into snake embryo 
fibroblasts
(Manvell et al., 2000)
Unsuccessful attempts*
Tortoise organ suspensions inoculated onto 
TH1 and VH2 cells
(Papp et al., 2010b)Page 47 of 49
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Pooled and/or individual snake organs 
inoculated onto monolayer of IgH2 cells
(Jacobson et al., 1980)
Lung suspension inoculated into embryonated 
snake eggs and then subcultured onto three 
piscine cell lines
(Clark et al., 1979)
Lung suspension inoculated into the allantois of 
SPF embryonated chicken eggs and onto 
chicken embryo fibroblasts and Vero cells
(Manvell et al., 2000)
Lung suspension inoculated onto VH2 cells and 
feline kidney cells (CRFK)
(Potgieter et al., 1987)
Reptilian paramyxovirus replicating in fathead 
minnow cells could not be subcultured into the 
allantois of SPF embryonated chicken eggs
(Potgieter et al., 1987)
Table 5 The methods that have been reported in the literature to isolate  1050
paramyxoviruses from reptiles. VH2 = viper heart cells. TH1 = terrapene heart  1051
cells. IgH2 = iguana heart cells. SPF = specific pathogen free. *Only those  1052
attempts where a paramyxovirus was successfully isolated using a different  1053
biological substrate are mentioned. This is to exclude the possibility that the  1054
unsuccessful attempt was because there was simply no virus in the inoculum.  1055
However, the possibility that the virus did grow in these cells but was not  1056
detected cannot be ruled out as further testing (e.g. polymerase chain reaction)  1057
was not performed. 1058
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Cell line
Cytopathic 
Effect
Viper 
heart 
cells 
(VH2)
Terrapene 
heart cells 
(TH1)
Vero 
cells
Iguana 
heart 
cells 
(IgH2)
Chicken 
embryo 
fibroblasts 
(LSCC-
H32)
Fathead 
minnow 
skin 
(FHM)
Various
§
Syncytial/giant 
cell formation
(Abbas et al., 
2011)
ф
(Jacobson et 
al., 1980; 
Jacobson et 
al., 1981; 
Blahak, 1995; 
Homer et al., 
1995; 
Jacobson et 
al., 2001)
(Jacobson et 
al., 2001)
#
(Richter
et al., 
1996)
1
(Mayr et 
al., 
2000)
2
(Jacobson
et al., 
2001)
3
(Ahne et 
al., 
1987; 
Ahne et 
al., 
1999b)
(Ahne et al., 
1999a)
2
(Potgieter
et al., 
1987)*
(Clark et 
al., 1979)
Cytoplasmic 
inclusion 
bodies
(Jacobson et 
al., 1981)
(Mayr et 
al., 
2000)
2
Cell 
lysis/monolayer 
destruction
(Abbas et al., 
2011)
ф
(Jacobson et 
al., 1981; 
Blahak, 1995; 
Homer et al., 
1995; 
Kolesnikovas
et al., 2006)
(Mayr et 
al., 
2000)
2
(Ahne et 
al., 
1987; 
Ahne et 
al., 
1999b)
(Ahne et al., 
1999a)
2
(Potgieter
et al., 
1987)*
(Clark et 
al., 1979)
Elongation of 
cell processes
(Homer et 
al., 1995)
Cell 
vacuolisation
(Ahne et al., 
1999a)
2
Cell rounding (Kolesnikovas
et al., 2006)
Table 6 The cytopathic effects of paramyxoviruses isolated from snakes and a  1061
lizard that have been described in the literature.
 § This isolate displayed CPE in  1062
nine reptilian and four mammalian cell lines after first being passaged through  1063
an embryonated snake egg.
1 Adapted from VH2 cells.
 2 Adapted from IgH2 cells. 1064
3 Adapted from TH1 cells. * Undescribed cytopathic changes were also seen  1065
when this isolate was propagated in hamster kidney cells (BHK-21), swine  1066
testicular cells (ST), Vero cells and primary bovine turbinate cells (BTU). 
# This  1067
isolate was obtained from a caiman lizard (Draecena guianensis). 
ф Tissue  1068
homogenates were inoculated onto VH2 and IgH2 cells but cell line that the  1069
isolate was successful isolated with is not specified. 1070
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Laboratory Reference
Haemagglutination Inhibition (HI)
Hohenheim University, Germany (Heard et al., 2004)
Chemical and Veterinary Investigation Office 
(CVUA) of East Westphalia-Lippe, Germany
(R. Marschang, pers. comm.)
Veterinary Laboratories Agency (VLA), UK (Keeble, 2004)
The University of Florida, USA (Heard et al., 2004)
The University of Tennessee, USA (Heard et al., 2004)
Texas State Diagnostic Laboratory, USA (Ritchie, 2006)
Polymerase Chain Reaction (PCR)
Hohenheim University, Germany* (R. Marschang, pers. comm.)
Chemical and Veterinary Investigation Office  
(CVUA) of East Westphalia-Lippe, Germany*
(R. Marschang, pers. comm.)
IDEXX Vet Med Labor, Germany http://www.idexx.de
Laboklin, Germany http://www.laboklin.de/
The University of Florida, USA* (Heard et al., 2004)
Murdoch University, Australia* (T. Hyndman, pers. comm.)
Virus Isolation
Hohenheim University, Germany (R. Marschang, pers. comm.)
Chemical and Veterinary Investigation Office 
(CVUA) of East Westphalia-Lippe, Germany
(R. Marschang, pers. comm.)
Table 7 Diagnostic tests for ferlavirus that are commercially available. *Known  1072
to use the primer pairs designed by Ahne et al. (1999b) targeting the L gene. 1073
1074